Publication | Open Access
The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway
161
Citations
28
References
2005
Year
Translational MedicineFibrosisUrologyRenal FunctionSmad2 PathwayMedicinePhysiologyPharmacologyRenal InflammationFibroblast Growth FactorHuman Renal FibroblastsAntifibrotic EffectsChronic Kidney DiseaseNephrologyKidney ResearchOxidative Stress
| Year | Citations | |
|---|---|---|
Page 1
Page 1